SpringerLink电子期刊(85)Elsevier电子期刊(16)
在“Elsevier电子期刊”中,命中:16条,耗时:小于0.01 秒

在所有数据库中总计命中:101

1.Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup
作者:William Bruno ; MD ; PhDa ; c ; Lorenza Pastorino ; PhDa ; c ; l.pastorino@unige.it" class="auth_mail" title="E-mail the corresponding author ; Paola Ghiorzo ; PhDa ; c ; Virginia Andreotti ; PhDa ; Claudia Martinuzzi ; MSca ; b ; Chiara Menin ; PhDg ; Lisa Elefanti ; PhDg ; Camilla Stagni ; PhDi ; Antonella Vecchiato ; MDh ; Monica Rodolfo ; PhDj ; Andrea Maurichi ; MDk ; Siranoush Manoukian ; MD ; PhDl ; Vincenzo De Giorgi ; MDm ; Imma Savarese ; MDm ; Francesca Gensini ; MD ; PhDn ; Lorenzo Borgognoni ; MDo ; Alessandro Testori ; MDp ; Giuseppe Spadola ; MDp ; Mario Mandalà ; MDq ; Gianlorenzo Imberti ; MDr ; Paola Savoia ; MDs ; Chiara Astrua ; MDs ; Anna Maria Ronco ; MDt ; Alessandra Farnetti ; MDt ; Maria Grazia Tibiletti ; PhDu ; Maurizio Lombardo ; MDv ; Giuseppe Palmieri ; PhDw ; Fabrizio Ayala ; MDx ; Paolo Ascierto ; MDx ; Giovanni Ghigliotti ; MDd ; Marisa Muggianu ; MDe ; Francesco Spagnolo ; MDe ; Virginia Picasso ; MDf ; Enrica Teresa Tanda ; MDf ; Paola Queirolo ; MDf ; Giovanna Bianchi-Scarrà ; PhDa ; c
刊名:Journal of the American Academy of Dermatology
出版年:2016
2.Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
4.Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
6.Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
刊名:Lancet Oncology
出版年:March, 2014
1
2
按检索点细分(16)
作者(16)
按出版年细分(16)
2027年及以后(5)
2016年(4)
2013年(1)
2012年(2)
2010年(1)
2009年(1)
2006年(2)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.